1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Chemotherapy 1.2.3 Radiation Therapy 1.2.4 Others 1.3 Market by Application 1.3.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Ambulatory Surgical Centers 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Perspective (2017-2028) 2.2 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Growth Trends by Region 2.2.1 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Historic Market Size by Region (2017-2022) 2.2.3 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Forecasted Market Size by Region (2023-2028) 2.3 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Dynamics 2.3.1 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Industry Trends 2.3.2 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Drivers 2.3.3 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Challenges 2.3.4 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Players by Revenue 3.1.1 Global Top B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Players by Revenue (2017-2022) 3.1.2 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Players (2017-2022) 3.2 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue 3.4 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Concentration Ratio 3.4.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue in 2021 3.5 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Key Players Head office and Area Served 3.6 Key Players B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product Solution and Service 3.7 Date of Enter into B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Breakdown Data by Type 4.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Historic Market Size by Type (2017-2022) 4.2 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Forecasted Market Size by Type (2023-2028) 5 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Breakdown Data by Application 5.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Historic Market Size by Application (2017-2022) 5.2 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size (2017-2028) 6.2 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type 6.2.1 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2017-2022) 6.2.2 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2023-2028) 6.2.3 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Type (2017-2028) 6.3 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application 6.3.1 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2017-2022) 6.3.2 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2023-2028) 6.3.3 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Application (2017-2028) 6.4 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country 6.4.1 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2017-2022) 6.4.2 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size (2017-2028) 7.2 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type 7.2.1 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2017-2022) 7.2.2 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2023-2028) 7.2.3 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Type (2017-2028) 7.3 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application 7.3.1 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2017-2022) 7.3.2 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2023-2028) 7.3.3 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Application (2017-2028) 7.4 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country 7.4.1 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2017-2022) 7.4.2 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size (2017-2028) 8.2 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type 8.2.1 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2017-2022) 8.2.2 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2023-2028) 8.2.3 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Type (2017-2028) 8.3 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application 8.3.1 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2017-2022) 8.3.2 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2023-2028) 8.3.3 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Application (2017-2028) 8.4 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region 8.4.1 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region (2017-2022) 8.4.2 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size (2017-2028) 9.2 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type 9.2.1 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2017-2022) 9.2.2 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2023-2028) 9.2.3 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Type (2017-2028) 9.3 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application 9.3.1 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2017-2022) 9.3.2 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2023-2028) 9.3.3 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Application (2017-2028) 9.4 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country 9.4.1 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2017-2022) 9.4.2 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size (2017-2028) 10.2 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type 10.2.1 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2017-2022) 10.2.2 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2023-2028) 10.2.3 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Type (2017-2028) 10.3 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application 10.3.1 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2017-2022) 10.3.2 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2023-2028) 10.3.3 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Application (2017-2028) 10.4 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country 10.4.1 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2017-2022) 10.4.2 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Amgen 11.1.1 Amgen Company Details 11.1.2 Amgen Business Overview 11.1.3 Amgen B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction 11.1.4 Amgen Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) 11.1.5 Amgen Recent Developments 11.2 Bayer 11.2.1 Bayer Company Details 11.2.2 Bayer Business Overview 11.2.3 Bayer B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction 11.2.4 Bayer Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) 11.2.5 Bayer Recent Developments 11.3 Bristol-Myers Squibb 11.3.1 Bristol-Myers Squibb Company Details 11.3.2 Bristol-Myers Squibb Business Overview 11.3.3 Bristol-Myers Squibb B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction 11.3.4 Bristol-Myers Squibb Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) 11.3.5 Bristol-Myers Squibb Recent Developments 11.4 Merck Serono 11.4.1 Merck Serono Company Details 11.4.2 Merck Serono Business Overview 11.4.3 Merck Serono B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction 11.4.4 Merck Serono Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) 11.4.5 Merck Serono Recent Developments 11.5 Roche 11.5.1 Roche Company Details 11.5.2 Roche Business Overview 11.5.3 Roche B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction 11.5.4 Roche Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) 11.5.5 Roche Recent Developments 11.6 AstraZeneca 11.6.1 AstraZeneca Company Details 11.6.2 AstraZeneca Business Overview 11.6.3 AstraZeneca B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction 11.6.4 AstraZeneca Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) 11.6.5 AstraZeneca Recent Developments 11.7 AbbVie 11.7.1 AbbVie Company Details 11.7.2 AbbVie Business Overview 11.7.3 AbbVie B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction 11.7.4 AbbVie Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) 11.7.5 AbbVie Recent Developments 11.8 Novartis 11.8.1 Novartis Company Details 11.8.2 Novartis Business Overview 11.8.3 Novartis B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction 11.8.4 Novartis Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) 11.8.5 Novartis Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

List of Tables Table 1. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Chemotherapy Table 3. Key Players of Radiation Therapy Table 4. Key Players of Others Table 5. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 6. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region (2017-2022) & (US$ Million) Table 8. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Region (2017-2022) Table 9. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Region (2023-2028) Table 11. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Trends Table 12. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Drivers Table 13. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Challenges Table 14. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Restraints Table 15. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue by Players (2017-2022) & (US$ Million) Table 16. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Share by Players (2017-2022) Table 17. Global Top B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment as of 2021) Table 18. Ranking of Global Top B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product Solution and Service Table 22. Date of Enter into B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2017-2022) & (US$ Million) Table 25. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Type (2017-2022) Table 26. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Type (2023-2028) Table 28. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2017-2022) & (US$ Million) Table 29. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Share by Application (2017-2022) Table 30. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Share by Application (2023-2028) Table 32. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2017-2022) & (US$ Million) Table 33. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2023-2028) & (US$ Million) Table 34. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2017-2022) & (US$ Million) Table 35. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2023-2028) & (US$ Million) Table 36. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2017-2022) & (US$ Million) Table 37. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2023-2028) & (US$ Million) Table 38. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2017-2022) & (US$ Million) Table 39. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2023-2028) & (US$ Million) Table 40. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2017-2022) & (US$ Million) Table 41. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2023-2028) & (US$ Million) Table 42. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2017-2022) & (US$ Million) Table 43. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2023-2028) & (US$ Million) Table 44. Asia Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2017-2022) & (US$ Million) Table 45. Asia Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2023-2028) & (US$ Million) Table 46. Asia Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2017-2022) & (US$ Million) Table 47. Asia Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2023-2028) & (US$ Million) Table 48. Asia Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region (2017-2022) & (US$ Million) Table 49. Asia Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region (2023-2028) & (US$ Million) Table 50. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2017-2022) & (US$ Million) Table 51. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2023-2028) & (US$ Million) Table 52. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2017-2022) & (US$ Million) Table 53. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2023-2028) & (US$ Million) Table 54. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2017-2022) & (US$ Million) Table 55. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2023-2028) & (US$ Million) Table 56. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2017-2022) & (US$ Million) Table 57. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2023-2028) & (US$ Million) Table 58. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2017-2022) & (US$ Million) Table 59. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2023-2028) & (US$ Million) Table 60. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2017-2022) & (US$ Million) Table 61. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2023-2028) & (US$ Million) Table 62. Amgen Company Details Table 63. Amgen Business Overview Table 64. Amgen B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product Table 65. Amgen Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) & (US$ Million) Table 66. Amgen Recent Developments Table 67. Bayer Company Details Table 68. Bayer Business Overview Table 69. Bayer B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product Table 70. Bayer Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) & (US$ Million) Table 71. Bayer Recent Developments Table 72. Bristol-Myers Squibb Company Details Table 73. Bristol-Myers Squibb Business Overview Table 74. Bristol-Myers Squibb B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product Table 75. Bristol-Myers Squibb Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) & (US$ Million) Table 76. Bristol-Myers Squibb Recent Developments Table 77. Merck Serono Company Details Table 78. Merck Serono Business Overview Table 79. Merck Serono B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product Table 80. Merck Serono Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) & (US$ Million) Table 81. Merck Serono Recent Developments Table 82. Roche Company Details Table 83. Roche Business Overview Table 84. Roche B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product Table 85. Roche Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) & (US$ Million) Table 86. Roche Recent Developments Table 87. AstraZeneca Company Details Table 88. AstraZeneca Business Overview Table 89. AstraZeneca B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product Table 90. AstraZeneca Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) & (US$ Million) Table 91. AstraZeneca Recent Developments Table 92. AbbVie Company Details Table 93. AbbVie Business Overview Table 94. AbbVie B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product Table 95. AbbVie Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) & (US$ Million) Table 96. AbbVie Recent Developments Table 97. Novartis Company Details Table 98. Novartis Business Overview Table 99. Novartis B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product Table 100. Novartis Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) & (US$ Million) Table 101. Novartis Recent Developments Table 102. Research Programs/Design for This Report Table 103. Key Data Information from Secondary Sources Table 104. Key Data Information from Primary Sources List of Figures Figure 1. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Type: 2021 VS 2028 Figure 2. Chemotherapy Features Figure 3. Radiation Therapy Features Figure 4. Others Features Figure 5. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Application: 2021 VS 2028 Figure 6. Hospitals Case Studies Figure 7. Clinics Case Studies Figure 8. Ambulatory Surgical Centers Case Studies Figure 9. Others Case Studies Figure 10. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Report Years Considered Figure 11. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Region: 2021 VS 2028 Figure 14. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Players in 2021 Figure 15. Global Top B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment as of 2021) Figure 16. The Top 10 and 5 Players Market Share by B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue in 2021 Figure 17. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 18. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Market Share by Type (2017-2028) Figure 19. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Market Share by Application (2017-2028) Figure 20. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Share by Country (2017-2028) Figure 21. United States B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Canada B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 24. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Market Share by Type (2017-2028) Figure 25. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Market Share by Application (2017-2028) Figure 26. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Share by Country (2017-2028) Figure 27. Germany B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. France B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. U.K. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Italy B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Russia B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Nordic Countries B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 34. Asia Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Market Share by Type (2017-2028) Figure 35. Asia Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Market Share by Application (2017-2028) Figure 36. Asia Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Share by Region (2017-2028) Figure 37. China B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Japan B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. South Korea B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Southeast Asia B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. India B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Australia B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 43. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 44. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Market Share by Type (2017-2028) Figure 45. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Market Share by Application (2017-2028) Figure 46. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Share by Country (2017-2028) Figure 47. Mexico B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. Brazil B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 49. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 50. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Market Share by Type (2017-2028) Figure 51. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Market Share by Application (2017-2028) Figure 52. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Share by Country (2017-2028) Figure 53. Turkey B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. Saudi Arabia B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. UAE B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 56. Amgen Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) Figure 57. Bayer Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) Figure 58. Bristol-Myers Squibb Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) Figure 59. Merck Serono Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) Figure 60. Roche Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) Figure 61. AstraZeneca Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) Figure 62. AbbVie Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) Figure 63. Novartis Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed

Amgen Bayer Bristol-Myers Squibb Merck Serono Roche AstraZeneca AbbVie Novartis